Goldman Sachs
MTNB icon

Goldman Sachs’s Matinas BioPharma MTNB Stock Holding History

Goldman Sachs’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-47
Closed -$17.6K – 6126
2022
Q4 		$17.6K Buy
+47
New +$23.5K ﹤0.01% 5711
2022
Q1 		– Sell
-62
Closed -$47K – 6789
2021
Q4 		$47K Buy
+62
New +$49.7K ﹤0.01% 6277
2021
Q2 		– Sell
-29
Closed -$23K – 6399
2021
Q1 		$23K Buy
+29
New +$29.2K ﹤0.01% 6003
2020
Q2 		– Sell
-324
Closed -$146K – 5382
2020
Q1 		$146K Buy
324
+208
+179% +$188K ﹤0.01% 4822
2019
Q4 		$198K Buy
+116
New +$101K ﹤0.01% 4898
2019
Q2 		– Sell
-81
Closed -$66K – 5279
2019
Q1 		$66K Buy
+81
New +$65.4K ﹤0.01% 4978
2018
Q4 		– Sell
-378
Closed -$261K – 5515
2018
Q3 		$261K Sell
378
-270
-42% -$87K ﹤0.01% 4784
2018
Q2 		$211K Buy
648
+627
+2,986% +$272K ﹤0.01% 4973
2018
Q1 		$12K Sell
21
-52
-71% -$41.2K ﹤0.01% 5728
2017
Q4 		$63K Buy
73
+46
+170% +$44.4K ﹤0.01% 5885
2017
Q3 		$26K Buy
27
+12
+80% +$12K ﹤0.01% 6391
2017
Q2 		$18K Sell
15
-281
-95% -$566K ﹤0.01% 6577
2017
Q1 		$614K Buy
+296
New +$724K ﹤0.01% 4827

Other funds holding MTNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Neville Rodie & Shaw
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
Arkadios Wealth Advisors
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
STALEY CAPITAL ADVISERS
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.67B AUM 20.47% 1-Year Est. Return

Goldman Sachs's MTNB Position: Q1 2023 in Review

Goldman Sachs sold out of Matinas BioPharma (MTNB) in Q1 2023, closing a stake of 47 shares — an estimated $17.6K sold.

Goldman Sachs first reported a position in MTNB in Q1 2017 and held it in 13 quarters. The position peaked at $614K in Q1 2017. 49 funds tracked by Wall St. Rank hold MTNB as of Q1 2023.

  • Goldman Sachs reported no remaining Matinas BioPharma position as of Q1 2023 after selling out during the quarter.
  • Goldman Sachs sold 47 Matinas BioPharma shares in Q1 2023, an estimated $17.6K.
  • Goldman Sachs first reported a position in Matinas BioPharma in Q1 2017 and held it in 13 quarters.
  • Goldman Sachs's Matinas BioPharma position peaked at $614K in Q1 2017.
  • 49 funds tracked by Wall St. Rank held Matinas BioPharma as of Q1 2023.

Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.